O'Connor Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
299
+26
+10% +$26.6K 0.13% 53
2026
Q1
$251K Buy
273
+5
+2% +$5.07K 0.1% 55
2025
Q4
$285K Buy
+268
New +$256K 0.11% 54
2025
Q3
Sell
-258
Closed -$201K 60
2025
Q2
$201K Buy
+258
New +$200K 0.09% 59
2024
Q4
Sell
-253
Closed -$224K 56
2024
Q3
$224K Sell
253
-4
-2% -$3.6K 0.12% 53
2024
Q2
$233K Buy
+257
New +$206K 0.14% 46

Other funds holding LLY

O'Connor Financial Group's LLY Position: Q2 2026 in Review

O'Connor Financial Group increased its Eli Lilly (LLY) stake by 9.5% in Q2 2026, buying an estimated $26.6K and bringing the position to 299 shares worth $359K. The position accounts for 0.13% of the portfolio, ranked #53.

O'Connor Financial Group first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • O'Connor Financial Group held 299 shares of Eli Lilly worth $359K as of Q2 2026.
  • O'Connor Financial Group bought 26 Eli Lilly shares in Q2 2026, an estimated $26.6K.
  • Eli Lilly made up 0.13% of O'Connor Financial Group's portfolio in Q2 2026, its #53 holding.
  • O'Connor Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on O'Connor Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.